Literature DB >> 23374886

An integrated pharmacokinetics ontology and corpus for text mining.

Heng-Yi Wu1, Shreyas Karnik, Abhinita Subhadarshini, Zhiping Wang, Santosh Philips, Xu Han, Chienwei Chiang, Lei Liu, Malaz Boustani, Luis M Rocha, Sara K Quinney, David Flockhart, Lang Li.   

Abstract

BACKGROUND: Drug pharmacokinetics parameters, drug interaction parameters, and pharmacogenetics data have been unevenly collected in different databases and published extensively in the literature. Without appropriate pharmacokinetics ontology and a well annotated pharmacokinetics corpus, it will be difficult to develop text mining tools for pharmacokinetics data collection from the literature and pharmacokinetics data integration from multiple databases. DESCRIPTION: A comprehensive pharmacokinetics ontology was constructed. It can annotate all aspects of in vitro pharmacokinetics experiments and in vivo pharmacokinetics studies. It covers all drug metabolism and transportation enzymes. Using our pharmacokinetics ontology, a PK-corpus was constructed to present four classes of pharmacokinetics abstracts: in vivo pharmacokinetics studies, in vivo pharmacogenetic studies, in vivo drug interaction studies, and in vitro drug interaction studies. A novel hierarchical three level annotation scheme was proposed and implemented to tag key terms, drug interaction sentences, and drug interaction pairs. The utility of the pharmacokinetics ontology was demonstrated by annotating three pharmacokinetics studies; and the utility of the PK-corpus was demonstrated by a drug interaction extraction text mining analysis.
CONCLUSIONS: The pharmacokinetics ontology annotates both in vitro pharmacokinetics experiments and in vivo pharmacokinetics studies. The PK-corpus is a highly valuable resource for the text mining of pharmacokinetics parameters and drug interactions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23374886      PMCID: PMC3571923          DOI: 10.1186/1471-2105-14-35

Source DB:  PubMed          Journal:  BMC Bioinformatics        ISSN: 1471-2105            Impact factor:   3.169


  14 in total

Review 1.  Drug interaction studies: study design, data analysis, and implications for dosing and labeling.

Authors:  S-M Huang; R Temple; D C Throckmorton; L J Lesko
Journal:  Clin Pharmacol Ther       Date:  2007-02       Impact factor: 6.875

2.  Literature mining on pharmacokinetics numerical data: a feasibility study.

Authors:  Zhiping Wang; Seongho Kim; Sara K Quinney; Yingying Guo; Stephen D Hall; Luis M Rocha; Lang Li
Journal:  J Biomed Inform       Date:  2009-04-02       Impact factor: 6.317

3.  Using a shallow linguistic kernel for drug-drug interaction extraction.

Authors:  Isabel Segura-Bedmar; Paloma Martínez; Cesar de Pablo-Sánchez
Journal:  J Biomed Inform       Date:  2011-04-24       Impact factor: 6.317

Review 4.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

5.  Stochastic prediction of CYP3A-mediated inhibition of midazolam clearance by ketoconazole.

Authors:  Jenny Y Chien; Aroonrut Lucksiri; Charles S Ernest; J Christopher Gorski; Steven A Wrighton; Stephen D Hall
Journal:  Drug Metab Dispos       Date:  2006-04-12       Impact factor: 3.922

6.  Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients.

Authors:  Silvana Borges; Zeruesenay Desta; Yan Jin; Azzouz Faouzi; Jason D Robarge; Sanosh Philips; Santosh Philip; Anne Nguyen; Vered Stearns; Daniel Hayes; James M Rae; Todd C Skaar; David A Flockhart; Lang Li
Journal:  J Clin Pharmacol       Date:  2010-01-15       Impact factor: 3.126

7.  Discovering drug-drug interactions: a text-mining and reasoning approach based on properties of drug metabolism.

Authors:  Luis Tari; Saadat Anwar; Shanshan Liang; James Cai; Chitta Baral
Journal:  Bioinformatics       Date:  2010-09-15       Impact factor: 6.937

Review 8.  Cytochrome p450 and chemical toxicology.

Authors:  F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2007-12-06       Impact factor: 3.739

9.  DrugBank 3.0: a comprehensive resource for 'omics' research on drugs.

Authors:  Craig Knox; Vivian Law; Timothy Jewison; Philip Liu; Son Ly; Alex Frolkis; Allison Pon; Kelly Banco; Christine Mak; Vanessa Neveu; Yannick Djoumbou; Roman Eisner; An Chi Guo; David S Wishart
Journal:  Nucleic Acids Res       Date:  2010-11-08       Impact factor: 16.971

10.  All-paths graph kernel for protein-protein interaction extraction with evaluation of cross-corpus learning.

Authors:  Antti Airola; Sampo Pyysalo; Jari Björne; Tapio Pahikkala; Filip Ginter; Tapio Salakoski
Journal:  BMC Bioinformatics       Date:  2008-11-19       Impact factor: 3.169

View more
  21 in total

1.  Big Data: Challenges and opportunities for clinical pharmacology.

Authors:  David Flockhart; Robert R Bies; Marc R Gastonguay; Sorell L Schwartz
Journal:  Br J Clin Pharmacol       Date:  2016-03-04       Impact factor: 4.335

2.  Mining Social Media Data for Biomedical Signals and Health-Related Behavior.

Authors:  Rion Brattig Correia; Ian B Wood; Johan Bollen; Luis M Rocha
Journal:  Annu Rev Biomed Data Sci       Date:  2020-05-04

3.  Applying a "Big Data" Literature System to Recommend Antihypertensive Drugs for Hypertension Patients with Diabetes Mellitus.

Authors:  Jing-Xian Shu; Ying Li; Ting He; Ling Chen; Xue Li; Lin-Lin Zou; Lu Yin; Xiao-Hui Li; An-Li Wang; Xing Liu; Hong Yuan
Journal:  Med Sci Monit       Date:  2018-01-07

4.  The potential of translational bioinformatics approaches for pharmacology research.

Authors:  Lang Li
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

5.  Translational drug-interaction corpus.

Authors:  Shijun Zhang; Hengyi Wu; Lei Wang; Gongbo Zhang; Luis M Rocha; Hagit Shatkay; Lang Li
Journal:  Database (Oxford)       Date:  2022-05-18       Impact factor: 4.462

6.  MONITORING POTENTIAL DRUG INTERACTIONS AND REACTIONS VIA NETWORK ANALYSIS OF INSTAGRAM USER TIMELINES.

Authors:  Rion Brattig Correia; Lang Li; Luis M Rocha
Journal:  Pac Symp Biocomput       Date:  2016

Review 7.  Translational Knowledge Discovery Between Drug Interactions and Pharmacogenetics.

Authors:  Heng-Yi Wu; Aditi Shendre; Shijun Zhang; Pengyue Zhang; Lei Wang; Desta Zeruesenay; Luis M Rocha; Hagit Shatkay; Sara K Quinney; Xia Ning; Lang Li
Journal:  Clin Pharmacol Ther       Date:  2020-02-03       Impact factor: 6.875

8.  Propensity score-adjusted three-component mixture model for drug-drug interaction data mining in FDA Adverse Event Reporting System.

Authors:  Xueying Wang; Lang Li; Lei Wang; Weixing Feng; Pengyue Zhang
Journal:  Stat Med       Date:  2019-12-27       Impact factor: 2.497

9.  Extraction of pharmacokinetic evidence of drug-drug interactions from the literature.

Authors:  Artemy Kolchinsky; Anália Lourenço; Heng-Yi Wu; Lang Li; Luis M Rocha
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

10.  Database: A New Article Type in CPT: Pharmacometrics & Systems Pharmacology.

Authors:  L Li; P H van der Graaf
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.